ArticlePharmaceuticals (Basel, Switzerland)2021

Semaphorin 3A-Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration.

Yolanda Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.